Axonics (AXNX)
(Real Time Quote from BATS)
$69.13 USD
-0.02 (-0.03%)
Updated Sep 23, 2024 01:36 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for Axonics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -6.09 | -59.70 | -80.07 | -54.92 | -79.94 |
Depreciation/Amortization & Depletion | 12.49 | 11.72 | 14.12 | 2.52 | 2.06 |
Net Change from Assets/Liabilities | -38.74 | -2.93 | -9.81 | -47.03 | -14.38 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 30.32 | 54.10 | 28.46 | 15.69 | 8.80 |
Net Cash From Operating Activities | -2.02 | 3.19 | -47.31 | -83.74 | -83.45 |
Property & Equipment | -3.55 | -2.22 | -2.26 | -2.94 | -1.34 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -140.74 | 0.00 | 0.00 |
Investments | -113.35 | -118.13 | 0.00 | 12.59 | 46.63 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -116.90 | -120.35 | -143.00 | 9.65 | 45.29 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.25 | 133.97 | 196.74 | 144.19 | 110.96 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -26.12 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -7.63 | 0.00 | -0.11 | 0.00 | 0.00 |
Net Cash from Financing Activities | -3.38 | 133.97 | 170.51 | 144.19 | 110.96 |
Effect of Exchange Rate Changes | 0.98 | 1.16 | -0.51 | 0.00 | -0.01 |
Net Change In Cash & Equivalents | -121.32 | 17.97 | -20.30 | 70.10 | 72.78 |
Cash at Beginning of Period | 238.85 | 220.88 | 241.18 | 171.08 | 98.31 |
Cash at End of Period | 117.53 | 238.85 | 220.88 | 241.18 | 171.08 |
Diluted Net EPS | -0.12 | -1.28 | -1.86 | -1.48 | -2.80 |
Fiscal Year End for Axonics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -12.21 | -19.11 | -6.09 | -12.66 | -16.59 |
Depreciation/Amortization & Depletion | 6.08 | 3.18 | 12.49 | 9.30 | 6.04 |
Net Change from Assets/Liabilities | -14.65 | -2.57 | -38.74 | -52.89 | -47.55 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 28.52 | 9.26 | 30.32 | 48.61 | 38.11 |
Net Cash From Operating Activities | 7.74 | -9.24 | -2.02 | -7.65 | -19.99 |
Property & Equipment | -4.30 | -3.06 | -3.55 | -2.24 | -1.05 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 65.36 | 141.29 | -113.35 | -76.74 | -66.88 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 61.06 | 138.23 | -116.90 | -78.98 | -67.93 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.49 | 0.25 | 4.25 | 3.67 | 2.79 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -7.63 | -7.63 | -7.63 |
Net Cash from Financing Activities | 0.49 | 0.25 | -3.38 | -3.96 | -4.84 |
Effect of Exchange Rate Changes | 0.43 | 1.70 | 0.98 | -0.94 | -0.75 |
Net Change In Cash & Equivalents | 69.72 | 130.95 | -121.32 | -91.52 | -93.50 |
Cash at Beginning of Period | 117.53 | 117.53 | 238.85 | 238.85 | 238.85 |
Cash at End of Period | 187.25 | 248.47 | 117.53 | 147.32 | 145.34 |
Diluted Net EPS | 0.13 | -0.38 | 0.14 | 0.08 | -0.15 |